Food demand shifts as Australian regulators approve daily weight-loss tablets. Celebrated restaurateur and cookbook author Karen Martini told The Sydney Morning Herald that the trend leaves her perplexed.
“What I find most disappointing is groups of well-dressed, thinner men and women out to lunch or dinner, who still want the experience of going out, eating and drinking,” Martini said.
Official figures show that 14.6 million Australians are overweight or obese, representing 67 per cent of adults and 27 per cent of children. These figures are expected to drop as GLP-1 medicines become cheaper and easier to use.
Australia’s medicine regulator approved two oral weight-loss pills: Eli Lilly’s daily tablet, marketed as Foundayo, and Novo Nordisk Pharmaceuticals’ Wegovy pill. Wegovy goes on sale on Friday, while Foundayo will be available in coming days.
Restaurant and Supermarket Adaptation
Australia’s $160 billion food and grocery sector finds itself at the front line of the GLP-1 boom. Supermarkets and restaurants are adjusting portion sizes to capture a user market projected to reach 30 per cent of adults within a decade.
Marley Spoon reports that 12 per cent of its sales now come from smaller GLP-1 support meals containing at least 20 grams of protein. Meanwhile, Sunrice released a Protein+ Rice product featuring 10 grams of protein from beef-derived collagen peptides to meet demand.

Fast-food chains such as McDonald’s are exploring smaller portions and higher protein options like egg bites and burger bowls for customers using the drugs.
Drugs cut appetite but raise malnutrition and muscle risks
The drugs reduce appetite and weight, but they also carry risks of nutritional deficiency and muscle loss. Dietitians Australia president Dr Fiona Willer warned that users face risks of malnutrition if they do not plan meals or receive professional health monitoring.
“You get full on much less food than before, so every mouthful counts when you’re on these drugs,” Willer said.
GLP-1 medications are subsidised through the Pharmaceutical Benefits Scheme for type 2 diabetes and cardiovascular disease, but not for weight loss alone. Patients seeking the treatment solely for weight management currently pay hundreds of dollars per month.
Frequently Asked Questions
When will the new oral weight-loss pills become available for purchase in Australia?
Novo Nordisk’s Wegovy pill goes on sale on Friday, while Eli Lilly’s Foundayo will be available in coming days.
How much do GLP-1 medications cost for patients using them strictly for weight loss?
Patients who want the drugs for weight loss must pay hundreds of dollars a month because the treatments are not currently subsidised through the Pharmaceutical Benefits Scheme for weight management alone.
Martini, who was born in 1971, left school at 15 after undertaking work experience at a Melbourne restaurant. She later became the founding chef at the Melbourne Wine Room and Sydney’s Icebergs Dining Room and Bar, where she held two chef’s hats and won a best new restaurant award.
What percentage of Australians are currently classified as overweight or obese?
Official figures show that 14.6 million Australians, or 67 per cent of adults and 27 per cent of children, are overweight or obese.